These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16874747)

  • 1. Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study.
    Kasparian NA; Meiser B; Butow PN; Soames Job RF; Mann GJ
    Psychooncology; 2007 Jan; 16(1):69-78. PubMed ID: 16874747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High- and average-risk individuals' beliefs about, and perceptions of, malignant melanoma: an Australian perspective.
    Kasparian NA; Butow PN; Meiser B; Mann GJ
    Psychooncology; 2008 Mar; 17(3):270-9. PubMed ID: 17600854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary melanoma and predictive genetic testing: why not?
    Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
    Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of genetic risk information in families with a high density of bipolar disorder: an exploratory study.
    Meiser B; Mitchell PB; McGirr H; Van Herten M; Schofield PR
    Soc Sci Med; 2005 Jan; 60(1):109-18. PubMed ID: 15482871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing in familial melanoma: uptake and implications.
    de Snoo FA; Riedijk SR; van Mil AM; Bergman W; ter Huurne JA; Timman R; Bertina W; Gruis NA; Vasen HF; van Haeringen A; Breuning MH; Tibben A
    Psychooncology; 2008 Aug; 17(8):790-6. PubMed ID: 18613292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community attitudes towards mental health interventions for healthy people on the basis of genetic susceptibility.
    Wilde A; Meiser B; Mitchell PB; Schofield PR
    Aust N Z J Psychiatry; 2009 Nov; 43(11):1070-6. PubMed ID: 20001402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families.
    Aspinwall LG; Leaf SL; Dola ER; Kohlmann W; Leachman SA
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1510-9. PubMed ID: 18559569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family members' perceptions of genetic testing for malignant melanoma--a prospective interview study.
    Bergenmar M; Hansson J; Brandberg Y
    Eur J Oncol Nurs; 2009 Apr; 13(2):74-80. PubMed ID: 19179113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the Threatening Medical Situations Inventory in individuals considering genetic testing for cancer risk.
    Wakefield CE; Homewood J; Mahmut M; Taylor A; Meiser B
    Patient Educ Couns; 2007 Dec; 69(1-3):29-38. PubMed ID: 17706910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests.
    Cameron LD; Sherman KA; Marteau TM; Brown PM
    Health Psychol; 2009 May; 28(3):307-16. PubMed ID: 19450036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
    Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous melanoma: family screening and genetic testing.
    Niendorf KB; Tsao H
    Dermatol Ther; 2006; 19(1):1-8. PubMed ID: 16405564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial impact of the lack of information given at referral about familial risk for cancer.
    Metcalfe A; Werrett J; Burgess L; Clifford C
    Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of information order on intentions to undergo predictive genetic testing: an experimental study.
    Morrison V; Henderson BJ; Taylor C; A'Ch Dafydd N; Unwin A
    J Health Psychol; 2010 Oct; 15(7):1082-92. PubMed ID: 20472604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gift or a yoke? Women's and men's responses to genetic risk information from BRCA1 and BRCA2 testing.
    d'Agincourt-Canning L
    Clin Genet; 2006 Dec; 70(6):462-72. PubMed ID: 17100990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
    Lewis MJ; Peterson SK
    Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of the life course paradigm and life course charts to explore referral for family history of breast cancer.
    Benjamin C; Flynn M; Hallett C; Ellis I; Booth K
    Int J Nurs Stud; 2008 Jan; 45(1):95-109. PubMed ID: 17157849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibility.
    Kasparian NA; Meiser B; Butow PN; Job RF; Mann GJ
    J Genet Couns; 2006 Dec; 15(6):433-47. PubMed ID: 17103321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Western Australian Melanoma Health Study: study design and participant characteristics.
    Ward SV; Cadby G; Lee A; Cole JM; Heyworth JS; Millward MJ; Wood FM; Palmer LJ
    Cancer Epidemiol; 2011 Oct; 35(5):423-31. PubMed ID: 21474410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.